The Plain Record

Neutral daily news — clear headlines, complete facts.

General

Uterine Fibroids Affect Most U.S. Women Amid Funding and Research Disparities

Uterine fibroids affect up to 80% of U.S. women and cost an estimated $34.4 billion annually, yet research remains significantly underfunded.

Published November 18, 2026 at 7:50 AM EST

The short answer

Uterine fibroids affect up to 80% of U.S. women and cost an estimated $34.4 billion annually, yet research remains significantly underfunded. Uterine fibroids, which are noncancerous muscle tumors that grow on the uterus, are estimated to affect 70% to 80% of women in the United States.

Uterine Fibroids Affect Most U.S. Women Amid Funding and Research Disparities

The Facts

Who
Dr. Soyini Hawkins and millions of U.S. women
What
Uterine fibroids research funding and health impact
Where
United States
Why
The condition is the leading cause of hysterectomies and has a multi-billion dollar economic impact despite low federal research priority.

Uterine fibroids, which are noncancerous muscle tumors that grow on the uterus, are estimated to affect 70% to 80% of women in the United States. Dr. Soyini Hawkins, a gynecologist and fibroid specialist, stated that while the condition is common, it remains under-researched and underfunded. The National Institutes of Health (NIH) allocates approximately $17 million annually to fibroid research, placing it in the bottom 40 of about 3,000 funded conditions.

The condition can cause heavy menstrual bleeding, pelvic pain, bloating, and fertility challenges. However, many patients do not experience symptoms unless the tumors grow large enough to alter the waistline or are positioned in specific areas of the uterus. Hawkins noted that hormones, specifically those responsible for pregnancy and menstruation, are the primary drivers of fibroid growth.

Research cited by Hawkins indicates a disparity in how the condition affects different demographics, with Black women being diagnosed two to three times more often than White women. Hawkins attributed this in part to lower vitamin D levels in women with more melanated skin, as melanin blocks sun penetration required for natural vitamin D production. She recommended vitamin D supplements as a potential preventative measure.

Diagnostic and treatment options vary. A standard ultrasound is the primary tool for detection. While fibroids are the leading cause of hysterectomies in the U.S., alternative treatments include myomectomies (surgical removal of the tumors while leaving the uterus intact), laparoscopic surgery, and radiofrequency ablation, which uses heat to shrink the growths. The choice of treatment typically depends on the size and location of the tumors and the patient's desire for future fertility.

For the individual patient, the condition often results in a concrete change to daily life through heavy bleeding and physical pain that can last for years. On average, women wait four years before seeking medical assistance, often due to the normalization of menstrual discomfort. Black women are particularly impacted, frequently presenting with more severe symptoms. A person with fibroids may notice their clothes fitting differently or experience significant changes in their menstrual cycle, affecting their ability to work or care for their families.

The high prevalence of the condition makes it the primary driver for hysterectomies nationwide, though specialists like Hawkins are advocating for a shift toward uterine-sparing procedures like myomectomies. These alternatives allow patients to maintain their fertility, as evidenced by Hawkins’ own experience of having two children following a myomectomy. Future progress depends on increased federal research funding and patients seeking earlier imaging, such as office-based ultrasounds, when they notice physical changes. No specific deadlines for new NIH funding or legislative changes were reported.

Summaries are written by The Plain Record to state the facts of a story plainly and without political slant. Drafted with AI assistance and checked against the source record before publication. See how we report, or report a correction.

← Back to the front page

Questions readers ask

What happened: Uterine Fibroids Affect Most U.S. Women Amid Funding and Research Disparities?

Uterine fibroids, which are noncancerous muscle tumors that grow on the uterus, are estimated to affect 70% to 80% of women in the United States. Dr. Soyini Hawkins, a gynecologist and fibroid specialist, stated that while the condition is common, it remains under-researched and underfunded.

Who is involved?

Dr. Soyini Hawkins and millions of U.S. women

When did this happen?

Not reported

Where did this happen?

United States

Why does this matter?

The condition is the leading cause of hysterectomies and has a multi-billion dollar economic impact despite low federal research priority.